user

Phase II trial of neoadjuvant capecitabine (C) with irinotecan (I) followed by capecitabine-based chemoradiotherapy (CRT) for patients (pts) with locally advanced rectal cancer (LARC): HOG GI03-53

被引：0
|
作者：
Cardenes, H. R.
Sanghani, S.
Burns, M.
Robb, M.
Hinkle, D. T.
Johnson, C. S.
Yu, M.
Currie, C. R.
Loehrer, P. J.
Chiorean, E. G.
机构：
[1] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[2] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[3] Hoosier Oncol Grp, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14026
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Concurrent radiotherapy with capecitabine and weekly irinotecan as neoadjuvant treatment for locally advanced rectal cancer: a phase I/II study
    Klautke, Gunther
    Feyerherd, Peter
    Ludwig, Kaja
    Foitzik, Thomas
    Klar, Ernst
    Fietkau, Rainer
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 80 - 80
  • [22] Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC).
    Shi, GG
    Lin, E
    Eng, C
    Delcos, M
    Crane, C
    Amos, CB
    Brown, T
    Abbruzzese, JL
    Skibber, J
    Janjan, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
  • [23] Which is the best partner for capecitabine-based neoadjuvant chemoradiotherapy in locally advanced rectal cancer? A retrospective analysis of a comprehensive cancer center
    Wang, J.
    Zhu, J.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [24] Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study
    Peng, Jianhong
    Lin, Junzhong
    Zeng, Zhifan
    Wu, Xiaojun
    Chen, Gong
    Li, Liren
    Lu, Zhenhai
    Ding, Peirong
    Wan, Desen
    Pan, Zhizhong
    [J]. ONCOLOGY LETTERS, 2017, 14 (04) : 4543 - 4550
  • [25] Phase IB/II study of neoadjuvant chemoradiotherapy with CRLX101 and capecitabine for locally advanced rectal cancer
    Wang, A.
    Sanoff, H.
    McRee, A.
    O'Neil, B.
    Calvo, B.
    Hennessy, M.
    Murphy, C.
    Tynan, M.
    Blackstock, W.
    Garmey, E.
    Tepper, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S341 - S341
  • [26] Capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer (PANDORA trial): Molecular profiling and translational results
    Tamberi, S.
    Marisi, G.
    Molinari, C.
    Grassi, E.
    Petracci, E.
    Angeli, D.
    Virga, A.
    Banchelli, I.
    Zingaretti, C.
    Pietrantonio, F.
    Gelsomino, F.
    Carandina, I.
    Banzi, M.
    Bonetti, A.
    Frassineti, G. L.
    Ugolini, G.
    Santucci, S.
    Longobardi, J.
    Ulivi, P.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1158 - S1158
  • [27] CETUXIMAB IN COMBINATION WITH CAPECITABINE, IRINOTECAN, AND RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER: RESULTS OF A PHASE II MARGIT TRIAL
    Horisberger, Karoline
    Treschl, Anne
    Mai, Sabine
    Barreto-Miranda, Manuel
    Kienle, Peter
    Stroebel, Philipp
    Erben, Philipp
    Woernle, Christoph
    Dinter, Dietmar
    Kaehler, Georg
    Hochhaus, Andreas
    Post, Stefan
    Willeke, Frank
    Wenz, Frederik
    Hofheinz, Ralf-Dieter
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1487 - 1493
  • [28] Phase I/II study of preoperative cetuximab, capecitabine and external beam radiotherapy in patients with locally advanced rectal cancer (LARC)
    Machiels, J.
    Coche, J.
    Scalliet, P.
    Van Cutsem, E.
    Roels, S.
    Canon, J.
    Coster, B.
    Kerger, J.
    Remouchamps, V.
    Haustermans, K.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 183 - 183
  • [29] VOLTAGE: Multicenter phase Ib/II study of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy (CRT) with capecitabine in patients with locally advanced rectal cancer (LARC)
    Bando, H.
    Tsukada, Y.
    Inamori, K.
    Fukuoka, S.
    Sasaki, T.
    Nishizawa, Y.
    Wakabayashi, M.
    Kojima, M.
    Togashi, Y.
    Yuki, S.
    Komatsu, Y.
    Homma, S.
    Hatanaka, Y.
    Matsuno, Y.
    Uemura, M.
    Kato, T.
    Sato, A.
    Nishikawa, H.
    Ito, M.
    Yoshino, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [30] EXCITE: A PHASE II TRIAL OF PREOPERATIVE CETUXIMAB, IRINOTECAN AND CAPECITABINE PLUS RADIOTHERAPY (RT) IN MRI-DEFINED LOCALLY ADVANCED RECTAL CANCER (LARC)
    Gollins, S.
    Myint, A. S.
    Saunders, M. P.
    Susnerwala, S.
    Sebag-Montefiori, D.
    Beare, S.
    Williams, E.
    West, N.
    Jitlal, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 206 - 207
12345